For a comprehensive
discussion on drug of abuse testing including typical detection time periods
see the DRUG
TESTING FAQ

Incorporating
a newly developed, patented collection device for human saliva samples, the
RAPIDSCREEN™6
is a self-contained, ready to use, point of contact, oral
fluid (saliva) drug testing device that detects
the six most common drugs
(or drug classes) of abuse: Marijuana (THC), Cocaine
(Benzoylecgonine), Opiates (or all opium
based drugs), Methamphetamine (and its derivatives),
Amphetamines (diet pills) and Phencyclidine (PCP) using the preferred lateral flow
immunoassay technology for this method of test screening. The test requires no
special training to complete and qualitative yes/no results are visibly obtained
atten minutes.Note: As with all visually
interpreted lateral flow tests, this assay provides only a preliminary analytical test result. A more specific alternative chemical method such as high-pressure liquid chromatography (HPLC)
or Gas chromatography/mass spectrometry (GC/MS) must be used in order to obtain
a confirmed analytical result. Clinical consideration and professional judgment should be applied to all test results, particularly when preliminary positive results are indicated.

Oral
Fluid Assay System For Drugs of Abuse

The RAPIDSCREEN™6forensic, oral
fluid based (saliva) drug testing system
detects the six most
commonly abused illicit and prescription drugs using a saliva sample. Because urine collection is
not necessary, there are certain advantages using the RAPIDSCREEN™6
system for on-site drug screening. Sample collection is less
hazardous, less embarrassing for the parties, and because there is no need for
privacy during sample collection, less prone to corruption by sample
substitution or adulteration. Because the test subject is
present for the entire sample collection andtesting process, the possibility of sample adulteration and/or
substitution is eliminated. The RAPIDSCREEN™6 will detect Marijuana
(THC), Cocaine (COC), Opiates (OPI), Methamphetamine (M-AMP),
Amphetamines (AMP)
and Phencyclidine (PCP) use at a
sensitivity level for saliva concentration* according to the following chart:

Target Drug

Nanograms
(ng)

per milliliter (ml)

Marijuana (THC)

12
ng/ml

Cocaine (COC)

20
ng/ml

Opiates (OPI)

40
ng/ml

Methamphetamine
(M-AMP)

50
ng/ml

Amphetamine (AMP)

50 ng/ml

Phencyclidine (PCP)

10 ng/ml

* Sensitivity detection levels for oral fluid (saliva) are considerably lower
than those for urine tests because the concentration of detectable drug metabolites
are significantly less in oral
fluids(saliva). The sensitivity cut-off levels above generally correlate
with the standards established for forensic urine tests by the NIDA,
SAMSHA and WHO.
For a technical document on the precision and specificity of saliva drug screens in relationship to urine based tests see the
Technical
Whitepaper on saliva based drug testing methods.

Additionally, the
RAPIDSCREEN™6 drug test will detect themetabolites and chemical derivatives of the class of drugs noted above
including all opium derivatives (codeine, heroin, etc.) and Methamphetamine
(ecstasy, amphetamine, etc.) Other features of using the
RAPIDSCREEN™6
drug test include:

The
RAPIDSCREEN™6 System is formulated for use with human oral fluid specimens (saliva)
using a basic step by step testing procedure.
Each test contains a sealed test device, sample collection
swab and special sample collection chamber. Confirm the expiration date printed on the test package. Do not open the test package until you are ready to perform the drug screen assay. If, necessary, bring the test pouch to room temperature . Insure that the person being tested has had nothing in their mouth for at least 5 minutes before sample collection. This includes water or other beverages (dilution) or food of any type (contamination). Directly observe the person during sample
collection.

Wait 10 minutes for
test results to fully develop. Test results are read by observing and scoring
whether red/pink lines develop on the test result panel as present or absent, 10 minutes after the sample was
added. Complete absence of a test line indicates a positive
test. Development of a test line, no matter how faint, indicates a negative
result for the labeled drug or drug metabolite. No correlation or assumptions
should be drawn on the color or intensity of test lines. Intensity and color
will vary line to line in the test panel and this result is both usual and
expected. Examples of test results

NEGATIVE

POSITIVE OPIATES

POSITIVE
M-AMP/PCP

POSITIVE THC

INVALID

A Negative test result is indicated by pink rose lines adjacent to each target drug label plus a control line.

A Positive test result is indicated by
the absence of a pink rose line adjacent to the OPI drug label plus a control line.

A Positive multiple test result is indicated by the absence of pink rose lines adjacent to each target drug label
(M-AMP/PCP) plus a control line.

A Positive test result is indicated by
the absence of a pink rose line adjacent to the THC drug label plus a control line.

Complete absence
of any lines on the test panel usually indicates an insufficient sample
was added to the sample well. Absence of a control line indicates an invalid
test

A
NEGATIVE test result is indicated by the development
and presence of a red/pink line adjacent to the labeled target drug.. If
there is a visible line, no matter how faint it may
be, the test should be considered negative result for the target drug. An extremely faint line could mean that the target drug is near the sensitivity cut-off level for the test
however the result is still negative.In such circumstances the test could be repeated at another time or a more quantitative method of laboratory testing be employed.A POSITIVE test result is indicated by the complete absence of a red/pink line at the position indicated for the drug in the test panel. More than one line may be absent indicating a multiple positive drug screen.An INVALID test result is indicated by the absence of a red/pink line at the (C) or control
position.Complete absence of any lines on the test panel
usually indicates an insufficient sample was added to the sample well and the
test must redone using another test device. Test cassettes are single use only
and cannot be reused.

The
RAPIDSCREEN 6™ Saliva Drug Testing System is
currently available for point
of contactdrug of abuse screening
in procedure packs of 25, 50, and 150 test packs. Each pack includes
complete test instruction and technical specifications of the test For
quantities exceeding 300 units please contact us by e-mail at
sales@craigmedical.com. Each test pack comes with individually sealed
test procedures containing one disposable collection syringe and one saliva test
cassette. RAPIDSCREEN 6™ Saliva Drug Tests are recommended for
institutional, professional, judicial, educational and workplace drug testing
programs and are intended for non-diagnostic *forensic use only.

Description

Quantity

Unit

Cost

RAPIDSCREEN™6 Six Panel Saliva Drug of Abuse Test

Twenty-Five (25) Tests

25 Pack Poly

$325.00

Fifty(50) Tests

50 Pack Poly

$590.00

One Hundred fifty(150) Tests

150 Pack Poly

$1,550.00

*If the
order buttons are absent or inoperable, please use the
pricing overview page to order.

*Forensic Use Only.
Not intended to be used in the diagnosis, cure, mitigation, treatment, or
prevention of a disease or illness. For initial indication of drug presence
only. Forensic use only tests are intended for use by legal and law enforcement
entities or laboratories testing for those entities. Not intended for home use.